Front Pharmacol 20(9):1261 Anjali Garg V, Dhiman A, Dutt R, Ranga S (2018) Health benefits of nutraceuticals
Better outcomes with GLP-1s in those with diabetes and peripheral arterial disease July 29, 2026 Summary: In a propensity-matched observational study of 2,133 pairs of patients with type 2 diabetes and peripheral artery disease, those prescribed GLP-1 receptor agonists had lower five-year rates of death, hospitalization, revascularization, and amputation than those prescribed metformin
Toradol and Zofran are medication-based relief injections, not vitamin injections
Factor #1: Weight loss restores ovulation (sometimes very quickly) The mechanism works like this: Excess body fat produces estrogen and disrupts normal ovulation, while fat cells also produce inflammatory compounds that interfere with reproductive hormones
Liraglutide, a oncedaily human GLP1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD1 SU)
Tesamorelin is FDA-approved in the US but holds no UK marketing authorisation